International Journal of Homoeopathic Sciences
Vol. 9, Issue 4, Part R (2025)
Clinical evaluation of Arnica montana 1m in post-stroke neurological deficits: An observational study
Ninad Prakash Kupwade, Harshvardhan S Bhosale and Bajirao A Shinde
Background: Stroke is a major global cause of death and disability, commonly resulting in long-term motor, sensory and cognitive deficits. Conventional management focuses on acute interventions and rehabilitation, but many patients are left with residual symptoms. Arnica montana 1M, a homoeopathic remedy traditionally used in trauma, vascular injury and inflammation, is proposed as an adjunct in stroke recovery.
Aim: To analyse the efficacy of Arnica montana 1M in the management of post-stroke neurological deficits.
Methods: An observational clinical study was conducted on 15 patients with clinically and radiologically diagnosed stroke, attending the Homoeopathic OPD of Late Mrs. Housabai Homoeopathic Medical College and Hospital, Nimshirgaon. Patients above 25 years of age with ischemic stroke, hemorrhagic stroke or transient ischemic attack (TIA) were included. All patients received Arnica montana 1M in individualized doses along with standard stroke care. Follow-up was done every 15 days for 2 months. Outcomes were assessed on the basis of neurological examination, changes in motor and speech function, subjective symptom relief and overall functional status.
Results: The study group comprised 10 males (66.67%) and 5 females (33.33%). Age incidence was highest in the 50-59 years group (46.67%), followed by 60-69 years (33.33%). Acute ischemic stroke was seen in 8 patients, hemorrhagic stroke in 3 patients and TIA in 4 patients. Overall, 13 patients (86.67%) showed some degree of clinical improvement, while 2 (13.33%) showed no response during the study period. Notable improvement in motor and speech function was observed in all hemorrhagic stroke cases and in most TIA cases, whereas ischemic stroke cases showed limited or no significant neurological recovery.
Conclusion: Arnica montana 1M may offer supportive benefit in post-stroke recovery, particularly in hemorrhagic stroke and TIA. Its role appears limited in established ischemic stroke. Larger, controlled studies are needed to validate these findings and to define the place of homoeopathic remedies within standard stroke rehabilitation protocols.
Pages: 1163-1166 | 306 Views 189 Downloads

